In type 2 diabetic mouse models, specific hydrolysates (RCPP-3, RNPP-1) improved glycaemic control and lipid metabolism through the stimulation of GLP-1 secretion via the activation of the intestinal calcium-sensing receptors and subsequent PI3K/Akt pathway activation [49]. Here, AKT1 is linked to type 2 diabetes mellitus.